| 000 | 01834 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250513212503.0 | ||
| 264 | 0 | _c20000711 | |
| 008 | 200007s 0 0 eng d | ||
| 022 | _a0160-564X | ||
| 024 | 7 |
_a10.1046/j.1525-1594.2000.06493.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aYomo, T | |
| 245 | 0 | 0 |
_aGlycoprotein IIb/IIIa receptor inhibitor attenuates platelet aggregation induced by thromboxane A2 during in vitro nonpulsatile ventricular assist circulation. _h[electronic resource] |
| 260 |
_bArtificial organs _cMay 2000 |
||
| 300 |
_a355-61 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdenosine Diphosphate _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aAdenosine Triphosphate _xmetabolism |
| 650 | 0 | 4 | _aAnalysis of Variance |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aBlood Platelets _xdrug effects |
| 650 | 0 | 4 |
_aCell Degranulation _xdrug effects |
| 650 | 0 | 4 |
_aCollagen _xantagonists & inhibitors |
| 650 | 0 | 4 | _aHeart-Assist Devices |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aPlatelet Aggregation _xdrug effects |
| 650 | 0 | 4 |
_aPlatelet Aggregation Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aPlatelet Count _xdrug effects |
| 650 | 0 | 4 |
_aPlatelet Glycoprotein GPIIb-IIIa Complex _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aRistocetin _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aThromboxane A2 _xantagonists & inhibitors |
| 650 | 0 | 4 | _aTirofiban |
| 650 | 0 | 4 |
_aTyrosine _xanalogs & derivatives |
| 700 | 1 | _aSerna, D L | |
| 700 | 1 | _aPowell, L L | |
| 700 | 1 | _aWang, D | |
| 700 | 1 | _aWilson, S E | |
| 700 | 1 | _aIshimaru, S | |
| 700 | 1 | _aChen, J C | |
| 773 | 0 |
_tArtificial organs _gvol. 24 _gno. 5 _gp. 355-61 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1046/j.1525-1594.2000.06493.x _zAvailable from publisher's website |
| 999 |
_c10799803 _d10799803 |
||